|
54
|
182
|
9pz0B |
Sars-cov-2 core polymerase complex with two utp incorporation |
|
29
|
73
|
9pyzC |
Sars-cov-2 core polymerase complex bound to rna, araump, and utp |
|
89
|
306
|
9nskA |
Room-temperature x-ray structure of sars-cov-2 main protease in complex with inhibitor bbh-3 |
|
86
|
306
|
9nslA |
Room-temperature x-ray structure of sars-cov-2 main protease in complex with with inhibitor bbh-4 |
|
89
|
302
|
9n6rA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with ensitrelvir |
|
88
|
305
|
9n6nA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with pomotrelvir |
|
88
|
305
|
9n6jA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion |
|
88
|
301
|
9n6pA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with ensitrelvir |
|
83
|
305
|
9n6mA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with nirmatrelvir |
|
84
|
305
|
9n6lA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with gc373 |
|
86
|
305
|
9mvmA |
Crystal structure of sars-cov-2 main protease (mpro)in complex with inhibitor avi-3318 |
|
87
|
301
|
9mvqA |
Crystal structure of sars-cov-2 main protease (mpro) variant q192t in complex with inhibitor avi-4303 |
|
91
|
305
|
9mvoA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with inhibitor avi-4692 |
|
77
|
305
|
9mvpA |
Crystal structure of sars-cov-2 main protease (mpro)in complex with inhibitor avi-4516 |
|
89
|
305
|
9n3mA |
Sars-cov-2 mpro l50f/e166a/l167f triple mutant bound to inhibitor |
|
85
|
301
|
9mdqA |
Crystal structure of sars-cov-2 omicron main protease (mpro) complex with azapeptide inhibitor 20a |
|
76
|
302
|
9m2vA |
Crystal structure of the sars-cov-2 (covid-19) main protease with inhibitor mc12 |
|
84
|
296
|
9kgqA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
81
|
299
|
9kgnA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
79
|
298
|
9kgjA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
83
|
302
|
9kgsA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
92
|
307
|
9kgrA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
88
|
300
|
9j8tA |
Crystal structure of sars-cov-2 main protease in complex with mp-4l2 |
|
82
|
301
|
9j8uA |
Crystal structure of sars-cov-2 main protease in complex with mp-4d7 |
|
235
|
926
|
9immA |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
248
|
926
|
9imkA |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
171
|
592
|
9immE |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
180
|
592
|
9imkE |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
17
|
113
|
9immG |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
17
|
113
|
9imkG |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
48
|
187
|
9immB |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
22
|
72
|
9immC |
Sars-cov-2 replication-transcription complex has a dimer architecture (local drtc) in post-capping state |
|
25
|
72
|
9imkC |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
47
|
187
|
9imkB |
Sars-cov-2 replication-transcription complex has a dimer architecture (drtc) in post-capping state |
|
192
|
592
|
9i53A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with atp |
|
196
|
592
|
9i51A |
Crystal structure of the sars-cov-2 helicase nsp13 in complex with adp |
|
84
|
304
|
9hfxA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097558 |
|
87
|
303
|
9hfyA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097078 |
|
79
|
305
|
9ghoA |
Structure of sars-cov-2 main protease (mpro) with mutation of s284a |
|
88
|
306
|
9ghnA |
Structure of sars-cov-2 main protease (mpro) with mutation of q256a |
|
35
|
131
|
9fwqA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00218 |
|
35
|
131
|
9fwsA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00258 |
|
34
|
130
|
9fwhA |
Crystal structure of sars-cov-2 nsp10-exon in complex with vt00019 |
|
83
|
302
|
9g0hA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the noncovalently bound inhibitor c5n17a |
|
74
|
286
|
9fwsB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00258 |
|
83
|
302
|
9g0iA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the noncovalently bound inhibitor c5n17b |
|
71
|
286
|
9fwhB |
Crystal structure of sars-cov-2 nsp10-exon in complex with vt00019 |
|
36
|
131
|
9fwpA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00198 |
|
35
|
131
|
9fwrA |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00249 |
|
70
|
285
|
9fwrB |
Crystal structure of sars-cov-2 nsp10-nsp14 (exon) in complex with vt00249 |
